QUT researchers created a biosensor using engineered proteins to detect and extract rare earth elements, offering a potential ...

Engineered to specifically act on the vascular endothelial growth factor receptor 2 (VEGFR2), BR55 (perfluorobutane/nitrogen ...

Scientists have found a molecular switch that reverses cancer cells in the body back to their normal, healthy state.

Caris Life Sciences ® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, announced today ...

The MASAI trial reveals AI in mammography increases cancer detection by 29% and decreases radiologists' workload by 44%, ...

Scientists at Osaka University have designed a nanogate that opens and closes using electrical signals, offering precise ...

In 2024, Myriad Genetics was awarded three patents related to foundational platform MRD technology and cell-free DNA preparation methods that each enable highly sensitive and specific tumor-informed, ...

NEW YORK – UK-based startup Oxford Cancer Analytics is using the $11 million it has raised in a Series A financing to further develop and commercialize its protein-based lung cancer screening assay.

This collaboration will streamline the ordering and delivery of molecular tests, enabling healthcare providers to electronically order and track Prolaris and MyRisk tests, with results delivered ...

A recent study conducted on human A(H5N1) cases in the United States found that conjunctivitis was the primary symptom ...